Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

Sponsor
Shahid Beheshti University of Medical Sciences
Study ID
NCT00370851
Phase
PHASE3
Status
Completed

Conditions

  • Retinal Disease

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

In this study we intend to evaluate the outcome of intravitreal avastin on improving the visual acuity and macular edema and late complications of BRVO like NVD and NVE

Key Dates

First listed
Sep 1, 2006
Start date
Aug 31, 2006
Status verified
Nov 2009
Primary completion
Feb 29, 2008
Completion
Jun 30, 2008

Study Design

Enrollment
82 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: 1
    Intravitreal injection of Avastin
  • Sham Comparator: 2

Primary Outcome Measure

Best corrected visual acuity [ Time Frame: At 12 week ]

Related Studies